NCIt definition : An orally available, Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic
activity. Polo-like kinase 1 inhibitor TAK-960 selectively inhibits PLK1, inducing
selective G2/M cell-cycle arrest followed by apoptosis in a variety of tumor cells
while causing reversible cell-cycle arrest at the G1 and G2 stages without apoptosis
in normal cells. PLK1 inhibition may result in the inhibition of proliferation in
PLK1-overexpressed tumor cells. PLK1, named after the polo gene of Drosophila melanogaster,
is a serine/threonine kinase crucial in the regulation of mitosis.;
UNII : 3831VFM1ZB;
CAS number : 1137868-52-0; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1137868-52-0
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;